BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3673975)

  • 1. Is medical therapy effective for regional lymphadenitis following BCG vaccination?
    Caglayan S; Yegin O; Kayran K; Timocin N; Kasirga E; Gun M
    Am J Dis Child; 1987 Nov; 141(11):1213-4. PubMed ID: 3673975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [BCG vaccination and increasing the effectiveness of treatment of post-vaccination complications by the use of rifampicin and dimexide].
    Mitinskaia LA; Iukhimenko NV; Kamaeva VF
    Probl Tuberk; 1994; (5):4-7. PubMed ID: 7870725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of suppuration in regional lymph nodes secondary to BCG vaccination.
    Caglayan S; Arikan A; Yaprak I; Aksoz K; Kansoy S
    Acta Paediatr Jpn; 1991 Dec; 33(6):699-702. PubMed ID: 1801547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional lymphadenitis following BCG vaccination (BCGitis). Clinical comments based upon 25 instances among 1295 childhood vaccinees.
    Chaves-Carballo E; Sanchez GA
    Clin Pediatr (Phila); 1972 Dec; 11(12):693-7. PubMed ID: 4639315
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical aspect and therapy of BCG-lymphadenitis (author's transl)].
    Lachmann D; Howanietz L
    Padiatr Padol; 1976; 11(1):283-6. PubMed ID: 1250626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of oral erythromycin and local isoniazid instillation therapy in infants with Bacillus Calmette-Guérin lymphadenitis and abscesses.
    Noah PK; Pande D; Johnson B; Ashley D
    Pediatr Infect Dis J; 1993 Feb; 12(2):136-9. PubMed ID: 8426771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lymphadenitis as a complication following vaccination with Bacillus Calmette-Guérin (BCG)].
    Cerdá de Palou E; de Santy HP
    Ned Tijdschr Geneeskd; 2003 Mar; 147(12):569-72. PubMed ID: 12693089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of regional lymphadenitis following BCG vaccination.
    Baki A; Oncü M; Usta S; Yildiz K; Karagüzel A
    Infection; 1991; 19(6):414-6. PubMed ID: 1816112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splitting the dose of neonatal BCG vaccination: a naïve practice.
    Fretzayas A; Moustaki M; Stefos E; Nicolaidou P
    Ann Trop Paediatr; 2009 Sep; 29(3):243-5. PubMed ID: 19689870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regional suppurative lymphadenitis after BCG vaccination (author's transl)].
    Brehmer W; Falkenberg N; Hussels H; Otto HS; Preussler H; Waldschmidt J
    Dtsch Med Wochenschr; 1977 Sep; 102(35):1251-5. PubMed ID: 902587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current problems of BCG innoculation of newborns and children].
    Habedank M
    Z Geburtshilfe Perinatol; 1979 Dec; 183(6):393-5. PubMed ID: 398103
    [No Abstract]   [Full Text] [Related]  

  • 12. BCG vaccination-induced suppurative lymphadenitis: four signs to pay attention to.
    Baek SO; Ko HS; Han HH
    Int Wound J; 2017 Dec; 14(6):1385-1387. PubMed ID: 28425207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical management of BCG vaccine-induced regional axillary lymphadenitis in HIV-infected children.
    Juzi JT; Sidler D; Moore SW
    S Afr J Surg; 2008 May; 46(2):52-5. PubMed ID: 18686936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacille Calmette-Guérin lymphadenitis.
    Goraya JS; Virdi VS
    Postgrad Med J; 2002 Jun; 78(920):327-9. PubMed ID: 12151684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adverse events following BCG vaccination in infants and children up to 36 months of age].
    Gołebiowska M; Andrzejewska E; Stryjewska I; Baranowska H; Drazkiewicz A
    Przegl Epidemiol; 2008; 62(1):71-5. PubMed ID: 18536227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of intradermal Bacillus Calmette-Guerin vaccine for neonates in Eastern Saudi Arabia.
    Al-Salem AH; Kothari MR; AlHani HM; Oquaish MM; Khogeer SS; Desouky MS
    Saudi Med J; 2012 Feb; 33(2):172-6. PubMed ID: 22327758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating clinical course of BCG lymphadenitis and factors affect on it during a 5-year period in Kerman, Iran.
    Daei Parizi M; Kardoust Parizi A; Izadipour S
    J Trop Pediatr; 2014 Apr; 60(2):148-53. PubMed ID: 24327454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Needle aspiration as a diagnostic tool and therapeutic modality in suppurative lymphadenitis following Bacillus Calmette Guerin vaccination.
    Sataynarayana S; Mathur AD; Verma Y; Pradhan S; Bhandari MK
    J Assoc Physicians India; 2002 Jun; 50():788-91. PubMed ID: 12240843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacillus Calmette-Guerin (BCG) lymphadenitis-changing trends and management.
    Nazir Z; Qazi SH
    J Ayub Med Coll Abbottabad; 2005; 17(4):16-8. PubMed ID: 16599027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG-Induced Granulomatous Balanoposthitis and Lymphadenitis Unresponsive to Isoniazid Therapy: A Case Report and Review of the Literature.
    Abello A; Das AK
    Clin Genitourin Cancer; 2018 Jun; 16(3):e533-e534. PubMed ID: 29463439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.